United States Hereceptin Biosimilar Market Report 2017

October 2017 | 95 pages | ID: U117FCEB6ABPEN
QYResearch

Abstracts

In this report, the United States Hereceptin Biosimilar market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Hereceptin Biosimilar in these regions, from 2012 to 2022 (forecast).

United States Hereceptin Biosimilar market competition by top manufacturers/players, with Hereceptin Biosimilar sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Mylan N.V.
• AryoGen Biopharma
• Genor Biopharma
• Celltrion Inc.
• Amgen Inc.
• Mabion S.A.
• The Instituto Vital Brazil
• F. Hoffmann-La Roche AG
• Biocon
• Gedeon Richter Plc

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Tablet
• Capsule

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Hereceptin Biosimilar for each application, including

• Pharmaceuticals
• Healthcare
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Hereceptin Biosimilar Market Report 2017

1 HERECEPTIN BIOSIMILAR OVERVIEW

1.1 Product Overview and Scope of Hereceptin Biosimilar
1.2 Classification of Hereceptin Biosimilar by Product Category
  1.2.1 United States Hereceptin Biosimilar Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Hereceptin Biosimilar Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Tablet
  1.2.4 Capsule
1.3 United States Hereceptin Biosimilar Market by Application/End Users
  1.3.1 United States Hereceptin Biosimilar Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Pharmaceuticals
  1.3.3 Healthcare
  1.3.4 Others
1.4 United States Hereceptin Biosimilar Market by Region
  1.4.1 United States Hereceptin Biosimilar Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Hereceptin Biosimilar Status and Prospect (2012-2022)
  1.4.3 Southwest Hereceptin Biosimilar Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Hereceptin Biosimilar Status and Prospect (2012-2022)
  1.4.5 New England Hereceptin Biosimilar Status and Prospect (2012-2022)
  1.4.6 The South Hereceptin Biosimilar Status and Prospect (2012-2022)
  1.4.7 The Midwest Hereceptin Biosimilar Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Hereceptin Biosimilar (2012-2022)
  1.5.1 United States Hereceptin Biosimilar Sales and Growth Rate (2012-2022)
  1.5.2 United States Hereceptin Biosimilar Revenue and Growth Rate (2012-2022)

2 UNITED STATES HERECEPTIN BIOSIMILAR MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Hereceptin Biosimilar Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Hereceptin Biosimilar Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Hereceptin Biosimilar Average Price by Players/Suppliers (2012-2017)
2.4 United States Hereceptin Biosimilar Market Competitive Situation and Trends
  2.4.1 United States Hereceptin Biosimilar Market Concentration Rate
  2.4.2 United States Hereceptin Biosimilar Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Hereceptin Biosimilar Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES HERECEPTIN BIOSIMILAR SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Hereceptin Biosimilar Sales and Market Share by Region (2012-2017)
3.2 United States Hereceptin Biosimilar Revenue and Market Share by Region (2012-2017)
3.3 United States Hereceptin Biosimilar Price by Region (2012-2017)

4 UNITED STATES HERECEPTIN BIOSIMILAR SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Hereceptin Biosimilar Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Hereceptin Biosimilar Revenue and Market Share by Type (2012-2017)
4.3 United States Hereceptin Biosimilar Price by Type (2012-2017)
4.4 United States Hereceptin Biosimilar Sales Growth Rate by Type (2012-2017)

5 UNITED STATES HERECEPTIN BIOSIMILAR SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Hereceptin Biosimilar Sales and Market Share by Application (2012-2017)
5.2 United States Hereceptin Biosimilar Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES HERECEPTIN BIOSIMILAR PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Mylan N.V.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Hereceptin Biosimilar Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Mylan N.V. Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 AryoGen Biopharma
  6.2.2 Hereceptin Biosimilar Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 AryoGen Biopharma Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Genor Biopharma
  6.3.2 Hereceptin Biosimilar Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Genor Biopharma Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Celltrion Inc.
  6.4.2 Hereceptin Biosimilar Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Celltrion Inc. Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Amgen Inc.
  6.5.2 Hereceptin Biosimilar Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Amgen Inc. Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Mabion S.A.
  6.6.2 Hereceptin Biosimilar Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Mabion S.A. Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 The Instituto Vital Brazil
  6.7.2 Hereceptin Biosimilar Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 The Instituto Vital Brazil Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 F. Hoffmann-La Roche AG
  6.8.2 Hereceptin Biosimilar Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 F. Hoffmann-La Roche AG Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Biocon
  6.9.2 Hereceptin Biosimilar Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Biocon Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Gedeon Richter Plc
  6.10.2 Hereceptin Biosimilar Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Gedeon Richter Plc Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 HERECEPTIN BIOSIMILAR MANUFACTURING COST ANALYSIS

7.1 Hereceptin Biosimilar Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Hereceptin Biosimilar

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Hereceptin Biosimilar Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Hereceptin Biosimilar Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HERECEPTIN BIOSIMILAR MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Hereceptin Biosimilar Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Hereceptin Biosimilar Sales Volume Forecast by Type (2017-2022)
11.3 United States Hereceptin Biosimilar Sales Volume Forecast by Application (2017-2022)
11.4 United States Hereceptin Biosimilar Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Hereceptin Biosimilar
Figure United States Hereceptin Biosimilar Market Size (MT) by Type (2012-2022)
Figure United States Hereceptin Biosimilar Sales Volume Market Share by Type (Product Category) in 2016
Figure Tablet Product Picture
Figure Capsule Product Picture
Figure United States Hereceptin Biosimilar Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of Hereceptin Biosimilar by Application in 2016
Figure Pharmaceuticals Examples
Table Key Downstream Customer in Pharmaceuticals
Figure Healthcare Examples
Table Key Downstream Customer in Healthcare
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Hereceptin Biosimilar Market Size (Million USD) by Region (2012-2022)
Figure The West Hereceptin Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Hereceptin Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Hereceptin Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Hereceptin Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Hereceptin Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Hereceptin Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Hereceptin Biosimilar Sales (MT) and Growth Rate (2012-2022)
Figure United States Hereceptin Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Hereceptin Biosimilar Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States Hereceptin Biosimilar Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States Hereceptin Biosimilar Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Hereceptin Biosimilar Sales Share by Players/Suppliers
Figure 2017 United States Hereceptin Biosimilar Sales Share by Players/Suppliers
Figure United States Hereceptin Biosimilar Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Hereceptin Biosimilar Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Hereceptin Biosimilar Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Hereceptin Biosimilar Revenue Share by Players/Suppliers
Figure 2017 United States Hereceptin Biosimilar Revenue Share by Players/Suppliers
Table United States Market Hereceptin Biosimilar Average Price (K USD/Kg) of Key Players/Suppliers (2012-2017)
Figure United States Market Hereceptin Biosimilar Average Price (K USD/Kg) of Key Players/Suppliers in 2016
Figure United States Hereceptin Biosimilar Market Share of Top 3 Players/Suppliers
Figure United States Hereceptin Biosimilar Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Hereceptin Biosimilar Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Hereceptin Biosimilar Product Category
Table United States Hereceptin Biosimilar Sales (MT) by Region (2012-2017)
Table United States Hereceptin Biosimilar Sales Share by Region (2012-2017)
Figure United States Hereceptin Biosimilar Sales Share by Region (2012-2017)
Figure United States Hereceptin Biosimilar Sales Market Share by Region in 2016
Table United States Hereceptin Biosimilar Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Hereceptin Biosimilar Revenue Share by Region (2012-2017)
Figure United States Hereceptin Biosimilar Revenue Market Share by Region (2012-2017)
Figure United States Hereceptin Biosimilar Revenue Market Share by Region in 2016
Table United States Hereceptin Biosimilar Price (K USD/Kg) by Region (2012-2017)
Table United States Hereceptin Biosimilar Sales (MT) by Type (2012-2017)
Table United States Hereceptin Biosimilar Sales Share by Type (2012-2017)
Figure United States Hereceptin Biosimilar Sales Share by Type (2012-2017)
Figure United States Hereceptin Biosimilar Sales Market Share by Type in 2016
Table United States Hereceptin Biosimilar Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Hereceptin Biosimilar Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Hereceptin Biosimilar by Type (2012-2017)
Figure Revenue Market Share of Hereceptin Biosimilar by Type in 2016
Table United States Hereceptin Biosimilar Price (K USD/Kg) by Types (2012-2017)
Figure United States Hereceptin Biosimilar Sales Growth Rate by Type (2012-2017)
Table United States Hereceptin Biosimilar Sales (MT) by Application (2012-2017)
Table United States Hereceptin Biosimilar Sales Market Share by Application (2012-2017)
Figure United States Hereceptin Biosimilar Sales Market Share by Application (2012-2017)
Figure United States Hereceptin Biosimilar Sales Market Share by Application in 2016
Table United States Hereceptin Biosimilar Sales Growth Rate by Application (2012-2017)
Figure United States Hereceptin Biosimilar Sales Growth Rate by Application (2012-2017)
Table Mylan N.V. Basic Information List
Table Mylan N.V. Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Mylan N.V. Hereceptin Biosimilar Sales Growth Rate (2012-2017)
Figure Mylan N.V. Hereceptin Biosimilar Sales Market Share in United States (2012-2017)
Figure Mylan N.V. Hereceptin Biosimilar Revenue Market Share in United States (2012-2017)
Table AryoGen Biopharma Basic Information List
Table AryoGen Biopharma Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure AryoGen Biopharma Hereceptin Biosimilar Sales Growth Rate (2012-2017)
Figure AryoGen Biopharma Hereceptin Biosimilar Sales Market Share in United States (2012-2017)
Figure AryoGen Biopharma Hereceptin Biosimilar Revenue Market Share in United States (2012-2017)
Table Genor Biopharma Basic Information List
Table Genor Biopharma Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Genor Biopharma Hereceptin Biosimilar Sales Growth Rate (2012-2017)
Figure Genor Biopharma Hereceptin Biosimilar Sales Market Share in United States (2012-2017)
Figure Genor Biopharma Hereceptin Biosimilar Revenue Market Share in United States (2012-2017)
Table Celltrion Inc. Basic Information List
Table Celltrion Inc. Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Celltrion Inc. Hereceptin Biosimilar Sales Growth Rate (2012-2017)
Figure Celltrion Inc. Hereceptin Biosimilar Sales Market Share in United States (2012-2017)
Figure Celltrion Inc. Hereceptin Biosimilar Revenue Market Share in United States (2012-2017)
Table Amgen Inc. Basic Information List
Table Amgen Inc. Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Amgen Inc. Hereceptin Biosimilar Sales Growth Rate (2012-2017)
Figure Amgen Inc. Hereceptin Biosimilar Sales Market Share in United States (2012-2017)
Figure Amgen Inc. Hereceptin Biosimilar Revenue Market Share in United States (2012-2017)
Table Mabion S.A. Basic Information List
Table Mabion S.A. Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Mabion S.A. Hereceptin Biosimilar Sales Growth Rate (2012-2017)
Figure Mabion S.A. Hereceptin Biosimilar Sales Market Share in United States (2012-2017)
Figure Mabion S.A. Hereceptin Biosimilar Revenue Market Share in United States (2012-2017)
Table The Instituto Vital Brazil Basic Information List
Table The Instituto Vital Brazil Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure The Instituto Vital Brazil Hereceptin Biosimilar Sales Growth Rate (2012-2017)
Figure The Instituto Vital Brazil Hereceptin Biosimilar Sales Market Share in United States (2012-2017)
Figure The Instituto Vital Brazil Hereceptin Biosimilar Revenue Market Share in United States (2012-2017)
Table F. Hoffmann-La Roche AG Basic Information List
Table F. Hoffmann-La Roche AG Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche AG Hereceptin Biosimilar Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche AG Hereceptin Biosimilar Sales Market Share in United States (2012-2017)
Figure F. Hoffmann-La Roche AG Hereceptin Biosimilar Revenue Market Share in United States (2012-2017)
Table Biocon Basic Information List
Table Biocon Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Biocon Hereceptin Biosimilar Sales Growth Rate (2012-2017)
Figure Biocon Hereceptin Biosimilar Sales Market Share in United States (2012-2017)
Figure Biocon Hereceptin Biosimilar Revenue Market Share in United States (2012-2017)
Table Gedeon Richter Plc Basic Information List
Table Gedeon Richter Plc Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Gedeon Richter Plc Hereceptin Biosimilar Sales Growth Rate (2012-2017)
Figure Gedeon Richter Plc Hereceptin Biosimilar Sales Market Share in United States (2012-2017)
Figure Gedeon Richter Plc Hereceptin Biosimilar Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hereceptin Biosimilar
Figure Manufacturing Process Analysis of Hereceptin Biosimilar
Figure Hereceptin Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of Hereceptin Biosimilar Major Players/Suppliers in 2016
Table Major Buyers of Hereceptin Biosimilar
Table Distributors/Traders List
Figure United States Hereceptin Biosimilar Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Hereceptin Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Hereceptin Biosimilar Price (K USD/Kg) Trend Forecast (2017-2022)
Table United States Hereceptin Biosimilar Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Hereceptin Biosimilar Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Hereceptin Biosimilar Sales Volume (MT) Forecast by Type in 2022
Table United States Hereceptin Biosimilar Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Hereceptin Biosimilar Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Hereceptin Biosimilar Sales Volume (MT) Forecast by Application in 2022
Table United States Hereceptin Biosimilar Sales Volume (MT) Forecast by Region (2017-2022)
Table United States Hereceptin Biosimilar Sales Volume Share Forecast by Region (2017-2022)
Figure United States Hereceptin Biosimilar Sales Volume Share Forecast by Region (2017-2022)
Figure United States Hereceptin Biosimilar Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources